Immunocore (IMCR) Presents Initial Phase 1 Data of ImmTAV streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The steep increase in liver cancer deaths is due to the rising rate of NAFLD, rather than alcoholic liver disease or hepatitis B or C, and is mostly driven by the obesity and type 2 diabetes epidemics.
Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™ streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.